RAMIPRIL (Northwind Pharmaceuticals)
Welcome to the PulseAid listing for the RAMIPRIL drug offered from Northwind Pharmaceuticals. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Northwind Pharmaceuticals |
NON-PROPRIETARY NAME: | RAMIPRIL |
SUBSTANCE NAME: | RAMIPRIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-12-30 |
END MARKETING DATE: | 0000-00-00 |
RAMIPRIL HUMAN PRESCRIPTION DRUG Details:
Item Description | RAMIPRIL from Northwind Pharmaceuticals |
LABELER NAME: | Northwind Pharmaceuticals |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2014-12-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51655-117_efbd9543-b8ae-43ef-8551-f0733760c751 |
PRODUCT NDC: | 51655-117 |
APPLICATION NUMBER: | ANDA076549 |
Other RAMIPRIL Pharmaceutical Manufacturers / Labelers: